These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 22322620

  • 21. Effect of two-day atorvastatin pretreatment on long-term outcome of patients with stable angina pectoris undergoing elective percutaneous coronary intervention.
    Veselka J, Zemánek D, Hájek P, Malý M, Adlová R, Martinkovičová L, Tomašov P, Tesař D.
    Am J Cardiol; 2011 May 01; 107(9):1295-9. PubMed ID: 21349484
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Preventive effect of statin pretreatment on contrast-induced acute kidney injury in patients undergoing coronary angioplasty: propensity score analysis from a multicenter registry.
    Hoshi T, Sato A, Kakefuda Y, Harunari T, Watabe H, Ojima E, Hiraya D, Abe D, Nishina H, Takeyasu N, Noguchi Y, Aonuma K.
    Int J Cardiol; 2014 Feb 01; 171(2):243-9. PubMed ID: 24393575
    [Abstract] [Full Text] [Related]

  • 25. Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study.
    Zemánek D, Branny M, Martinkovičová L, Hájek P, Malý M, Tesař D, Tomašov P, Veselka J.
    Int J Cardiol; 2013 Oct 03; 168(3):2494-7. PubMed ID: 23597577
    [Abstract] [Full Text] [Related]

  • 26. Effectiveness of preprocedural statin therapy on clinical outcomes for patients with stable coronary artery disease after percutaneous coronary interventions.
    Ko DT, Wijeysundera HC, Yun L, Austin PC, Cantor WJ, Tu JV.
    Circ Cardiovasc Qual Outcomes; 2011 Jul 03; 4(4):459-66. PubMed ID: 21712520
    [Abstract] [Full Text] [Related]

  • 27. Meta-analysis of published reports on the effect of statin treatment before percutaneous coronary intervention on periprocedural myonecrosis.
    Merla R, Reddy NK, Wang FW, Uretsky BF, Barbagelata A, Birnbaum Y.
    Am J Cardiol; 2007 Sep 01; 100(5):770-6. PubMed ID: 17719318
    [Abstract] [Full Text] [Related]

  • 28. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
    Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G, ARMYDA Investigators.
    Circulation; 2004 Aug 10; 110(6):674-8. PubMed ID: 15277322
    [Abstract] [Full Text] [Related]

  • 29. Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial.
    Leone AM, Rutella S, Giannico MB, Perfetti M, Zaccone V, Brugaletta S, Garramone B, Niccoli G, Porto I, Liuzzo G, Biasucci LM, Bellesi S, Galiuto L, Leone G, Rebuzzi AG, Crea F.
    Int J Cardiol; 2008 Nov 28; 130(3):457-62. PubMed ID: 18667247
    [Abstract] [Full Text] [Related]

  • 30. Meta-analysis of the role of high-dose statins administered prior to percutaneous coronary intervention in reducing major adverse cardiac events in patients with coronary artery disease.
    Hao PP, Chen YG, Wang JL, Ji WQ, Xue L, Liu XH, Wang XL, Zhang Y.
    Clin Exp Pharmacol Physiol; 2010 Apr 28; 37(4):496-500. PubMed ID: 19930422
    [Abstract] [Full Text] [Related]

  • 31. Meta-analysis of the role of statin therapy in reducing myocardial infarction following elective percutaneous coronary intervention.
    Mood GR, Bavry AA, Roukoz H, Bhatt DL.
    Am J Cardiol; 2007 Sep 15; 100(6):919-23. PubMed ID: 17826370
    [Abstract] [Full Text] [Related]

  • 32. A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes.
    Marenzi G, Cosentino N, Werba JP, Tedesco CC, Veglia F, Bartorelli AL.
    Int J Cardiol; 2015 Mar 15; 183():47-53. PubMed ID: 25662053
    [Abstract] [Full Text] [Related]

  • 33. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
    Veselka J, Zemánek D, Hájek P, Malý M, Adlová R, Martinkovicová L, Tesar D.
    Am J Cardiol; 2009 Sep 01; 104(5):630-3. PubMed ID: 19699335
    [Abstract] [Full Text] [Related]

  • 34. The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome.
    Yun KH, Jeong MH, Oh SK, Rhee SJ, Park EM, Lee EM, Yoo NJ, Kim NH, Ahn YK, Jeong JW.
    Int J Cardiol; 2009 Nov 12; 137(3):246-51. PubMed ID: 18706705
    [Abstract] [Full Text] [Related]

  • 35. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z, Kala P.
    Clin Ther; 2008 Nov 12; 30 Pt 2():2191-202. PubMed ID: 19281914
    [Abstract] [Full Text] [Related]

  • 36. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.
    Patti G, Nusca A, Chello M, Pasceri V, D'Ambrosio A, Vetrovec GW, Di Sciascio G.
    Am J Cardiol; 2008 Feb 01; 101(3):279-85. PubMed ID: 18237585
    [Abstract] [Full Text] [Related]

  • 37. Preprocedural statin use in patients undergoing percutaneous coronary intervention.
    Kenaan M, Seth M, Aronow HD, Naoum J, Wunderly D, Mitchiner J, Moscucci M, Gurm HS, Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    Am Heart J; 2014 Jul 01; 168(1):110-6.e3. PubMed ID: 24952867
    [Abstract] [Full Text] [Related]

  • 38. Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention.
    Kandula P, Shah R, Singh N, Markwell SJ, Bhensdadia N, Navaneethan SD.
    Nephrology (Carlton); 2010 Mar 01; 15(2):165-70. PubMed ID: 20470274
    [Abstract] [Full Text] [Related]

  • 39. Short-term atorvastatin preload reduces levels of adhesion molecules in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Results from the ARMYDA-ACS CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.
    Patti G, Chello M, Gatto L, Alfano G, Miglionico M, Covino E, Di Sciascio G.
    J Cardiovasc Med (Hagerstown); 2010 Nov 01; 11(11):795-800. PubMed ID: 20613550
    [Abstract] [Full Text] [Related]

  • 40. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.
    Patti G, Pasceri V, Colonna G, Miglionico M, Fischetti D, Sardella G, Montinaro A, Di Sciascio G.
    J Am Coll Cardiol; 2007 Mar 27; 49(12):1272-8. PubMed ID: 17394957
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.